Ami Organics Ltd
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]
- Market Cap ₹ 4,555 Cr.
- Current Price ₹ 1,235
- High / Low ₹ 1,389 / 1,004
- Stock P/E 76.6
- Book Value ₹ 183
- Dividend Yield 0.24 %
- ROCE 16.0 %
- ROE 9.39 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 18.1%
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
160 | 188 | 239 | 240 | 341 | 520 | 617 | 717 | |
137 | 157 | 196 | 198 | 260 | 415 | 493 | 589 | |
Operating Profit | 23 | 31 | 42 | 42 | 80 | 105 | 123 | 128 |
OPM % | 14% | 16% | 18% | 17% | 24% | 20% | 20% | 18% |
0 | 3 | 0 | 2 | 1 | 3 | 4 | -25 | |
Interest | 3 | 3 | 5 | 6 | 6 | 6 | 2 | 6 |
Depreciation | 1 | 2 | 3 | 4 | 4 | 10 | 12 | 16 |
Profit before tax | 19 | 28 | 35 | 35 | 72 | 91 | 112 | 82 |
Tax % | 35% | 35% | 34% | 21% | 25% | 21% | 26% | 41% |
12 | 18 | 23 | 27 | 54 | 72 | 83 | 49 | |
EPS in Rs | 80.33 | 123.33 | 22.19 | 26.16 | 17.14 | 19.75 | 22.86 | 11.60 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 15% | 13% | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 28% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 3% |
TTM: | -29% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 14% |
Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 2 | 2 | 10 | 10 | 32 | 36 | 36 | 37 |
Reserves | 37 | 56 | 72 | 101 | 135 | 486 | 558 | 637 |
27 | 44 | 54 | 59 | 137 | 1 | 4 | 217 | |
43 | 54 | 77 | 61 | 110 | 136 | 169 | 205 | |
Total Liabilities | 109 | 155 | 213 | 232 | 413 | 659 | 767 | 1,096 |
28 | 32 | 79 | 85 | 186 | 205 | 259 | 427 | |
CWIP | 11 | 30 | 2 | 12 | 0 | 3 | 30 | 125 |
Investments | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 0 |
68 | 91 | 131 | 133 | 225 | 450 | 477 | 543 | |
Total Assets | 109 | 155 | 213 | 232 | 413 | 659 | 767 | 1,096 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
29 | 8 | 15 | 27 | 28 | -12 | 66 | 125 | |
-19 | -25 | -21 | -24 | -101 | -121 | -33 | -365 | |
-7 | 15 | 6 | 0 | 72 | 140 | -12 | 239 | |
Net Cash Flow | 3 | -2 | -0 | 3 | -1 | 8 | 20 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 83 | 97 | 116 | 86 | 129 | 115 | 136 | 105 |
Inventory Days | 76 | 89 | 95 | 148 | 123 | 150 | 131 | 139 |
Days Payable | 148 | 154 | 168 | 146 | 172 | 158 | 157 | 119 |
Cash Conversion Cycle | 11 | 31 | 43 | 88 | 80 | 107 | 111 | 125 |
Working Capital Days | 46 | 64 | 68 | 86 | 119 | 141 | 149 | 132 |
ROCE % | 38% | 34% | 27% | 33% | 24% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
17 May - Transcript of Earnings Call for Q4 FY24 financial results on May 13, 2024 is enclosed
-
Announcement under Regulation 30 (LODR)-Investor Presentation
16 May - Presentation of the Company is herewith enclosed.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 15 May
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 15 May
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 May - Newspaper publication of Financial Results for the quarter and year ending as on March 31, 2024 is herewith enclosed.
Annual reports
Concalls
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript PPT
Business Overview
AMI Organics is a manufacturer of specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic APIs and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals. It has developed and commercialized over 520 products across 50 countries, supplied to over 500 customers. [1]